MedPath

University of Maryland

University of Maryland logo
🇺🇸United States
Ownership
Private
Established
1856-01-01
Employees
10K
Market Cap
-
Website
http://www.umd.edu

Clinical Trials

4

Active:0
Completed:4

Trial Phases

2 Phases

Phase 4:1
Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (75.0%)
Phase 4
1 (25.0%)

Physical Telerehabilitation in Veterans With Multiple Sclerosis

Not Applicable
Completed
Conditions
Multiple Sclerosis
First Posted Date
2015-01-27
Last Posted Date
2017-05-05
Lead Sponsor
University of Maryland
Target Recruit Count
74
Registration Number
NCT02346734
Locations
🇺🇸

University of Maryland, Baltimore, Maryland, United States

CASA: Care and Support Access in HIV Disease

Not Applicable
Completed
Conditions
HIV/AIDS
First Posted Date
2014-05-13
Last Posted Date
2019-06-04
Lead Sponsor
University of Maryland
Target Recruit Count
197
Registration Number
NCT02136680
Locations
🇺🇸

University of Maryland Medical System, Baltimore, Maryland, United States

Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores

Not Applicable
Completed
Conditions
End-Stage Renal Disease
Interventions
First Posted Date
2011-12-21
Last Posted Date
2018-06-14
Lead Sponsor
University of Maryland
Target Recruit Count
20
Registration Number
NCT01496417
Locations
🇺🇸

University of Maryland, Baltimore, Maryland, United States

Bupivacaine Versus Lidocaine on Inflammatory Regulation

Phase 4
Completed
Conditions
Pain
Interventions
First Posted Date
2010-02-02
Last Posted Date
2018-05-31
Lead Sponsor
University of Maryland
Target Recruit Count
11
Registration Number
NCT01060774
Locations
🇺🇸

University of Maryland, Baltimore College of Dental Surgery, Baltimore, Maryland, United States

News

Maryland Stem Cell Research Fund Allocates $18 Million to Advance Regenerative Medicine Research

The Maryland Stem Cell Research Commission has awarded over $18 million in grants to 52 investigators working on nearly 50 different medical conditions including sickle cell anemia, diabetes, and various neurological disorders.

Novel MRI Biomarker Shows Promise for Early Detection of Heart Damage in Duchenne Muscular Dystrophy

University of Maryland researchers discovered that MRI-derived septal circumferential strain can detect early cardiac dysfunction in Duchenne muscular dystrophy patients before traditional markers appear.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.